Follow
Marisol Romero Tejeda
Marisol Romero Tejeda
Verified email at u.northwestern.edu
Title
Cited by
Cited by
Year
Negligible-cost and weekend-free chemically defined human iPSC culture
HH Kuo, X Gao, JM DeKeyser, KA Fetterman, EA Pinheiro, CJ Weddle, ...
Stem Cell Reports 14 (2), 256-270, 2020
1082020
Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity
T Magdy, M Jouni, HH Kuo, CJ Weddle, D Lyra-Leite, H Fonoudi, ...
Circulation 145 (4), 279-294, 2022
542022
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
T Magdy, Z Jiang, M Jouni, H Fonoudi, D Lyra-Leite, G Jung, ...
Cell stem cell 28 (12), 2076-2089. e7, 2021
502021
Enhanced immune activation linked to endotoxemia in HIV-1 seronegative MSM
CD Palmer, J Tomassilli, M Sirignano, M Romero-Tejeda, KB Arnold, ...
Aids 28 (14), 2162-2166, 2014
362014
Are these cardiomyocytes? Protocol development reveals impact of sample preparation on the accuracy of identifying cardiomyocytes by flow cytometry
M Waas, R Weerasekera, EM Kropp, M Romero-Tejeda, EN Poon, ...
Stem Cell Reports 12 (2), 395-410, 2019
202019
Naturally occurring subclinical endotoxemia in humans alters adaptive and innate immune functions through reduced MAPK and increased STAT1 phosphorylation
CD Palmer, M Romero-Tejeda, M Sirignano, S Sharma, TM Allen, ...
The Journal of Immunology 196 (2), 668-677, 2016
192016
CCR5-Δ32 heterozygosity, HIV-1 reservoir size, and lymphocyte activation in individuals receiving long-term suppressive antiretroviral therapy
TJ Henrich, E Hanhauser, LJ Harrison, CD Palmer, M Romero-Tejeda, ...
The Journal of Infectious Diseases 213 (5), 766-770, 2016
142016
Elevated Levels of Microbial Translocation Markers and CCL2 Among Older HIV-1–Infected Men
E Scully, A Lockhart, L Huang, Y Robles, C Becerril, M Romero-Tejeda, ...
The Journal of Infectious Diseases 213 (5), 771-775, 2016
92016
Increased frequencies of CD8+ CD57+ T cells are associated with antibody neutralization breadth against HIV in viraemic controllers
CD Palmer, M Romero‐Tejeda, EP Scully, A Lockhart, MS Seaman, ...
African Journal of Reproduction and Gynaecological Endoscopy 19 (1), 2016
82016
A novel transcription factor combination for direct reprogramming to a spontaneously contracting human cardiomyocyte-like state
M Romero-Tejeda, H Fonoudi, CJ Weddle, JM DeKeyser, B Lenny, ...
Journal of molecular and cellular cardiology 182, 30-43, 2023
12023
Generation and Application of Human Pluripotent Stem Cell-Derived Cardiomyocytes
AJT Schuldt, M Romero-Tejeda, PW Burridge
Cardiac Regeneration, 67-106, 2017
12017
In vivo plasma LPS levels in HIV negative subjects alter T cell proliferative responses, stimulate cytokine release and induce TLR cross tolerance in monocytes ex vivo (IRC4P. 604)
C Palmer, M Romero-Tejeda, M Sirignano, S Sharma, T Allen, M Altfeld, ...
The Journal of Immunology 194 (1_Supplement), 57.21-57.21, 2015
12015
HIV elite controllers have lower frequencies of CD14dimCD16+ inflammatory monocytes with greater CX3CR1-dependent tissue homing potential than viremic controllers (VIR9P. 1138)
C Palmer, M Romero-Tejeda, E Scully, S Jost, M Seaman, A Goldenthal, ...
The Journal of Immunology 194 (1_Supplement), 215.4-215.4, 2015
12015
Abstract P1031: A Novel Transcription Factor Combination For Direct Reprogramming To A Spontaneously Contracting Human Cardiomyocyte-Like State
M Romero Tejeda, H Fonoudi, CJ Weddle, JM DeKeyser, CL Epting, ...
Circulation Research 131 (Suppl_1), AP1031-AP1031, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–14